Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quercetin for Postoperative Pain Following Cesarean Section
NCT06650891Phase 3Completed
- Sponsor
- Future University in Egypt
- Start
- Oct 2024
- Primary completion
- Jan 2025
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Quercetin with Placebo (2 arms). Primary endpoint: Pain intensity at 24 hours. Started Oct 2024; status: completed.
02
Drugs
quercetin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06650891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06650891.